Dean Capital Management boosted its position in Helmerich & Payne, Inc. (NYSE:HP - Free Report) by 136.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,964 shares of the oil and gas company's stock after buying an additional 69,704 shares during the quarter. Helmerich & Payne makes up approximately 1.6% of Dean Capital Management's portfolio, making the stock its 2nd biggest position. Dean Capital Management owned about 0.12% of Helmerich & Payne worth $3,873,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in HP. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Helmerich & Payne by 18.6% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 413,542 shares of the oil and gas company's stock worth $13,242,000 after buying an additional 64,971 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Helmerich & Payne in the 4th quarter worth approximately $2,788,000. Private Capital Management LLC bought a new position in Helmerich & Payne during the 3rd quarter valued at approximately $1,095,000. Fisher Asset Management LLC boosted its holdings in Helmerich & Payne by 4.6% in the fourth quarter. Fisher Asset Management LLC now owns 1,413,749 shares of the oil and gas company's stock worth $45,268,000 after acquiring an additional 62,377 shares in the last quarter. Finally, Legato Capital Management LLC grew its stake in shares of Helmerich & Payne by 93.9% in the fourth quarter. Legato Capital Management LLC now owns 76,064 shares of the oil and gas company's stock worth $2,436,000 after acquiring an additional 36,828 shares during the last quarter. 96.05% of the stock is currently owned by institutional investors.
Helmerich & Payne Price Performance
Helmerich & Payne stock traded down $0.06 during mid-day trading on Friday, hitting $18.28. The stock had a trading volume of 1,713,775 shares, compared to its average volume of 1,543,372. The firm's 50 day moving average is $22.20 and its 200 day moving average is $28.87. The company has a current ratio of 2.81, a quick ratio of 2.52 and a debt-to-equity ratio of 0.60. Helmerich & Payne, Inc. has a one year low of $17.60 and a one year high of $42.60. The firm has a market capitalization of $1.82 billion, a P/E ratio of 6.01, a P/E/G ratio of 3.52 and a beta of 0.93.
Helmerich & Payne (NYSE:HP - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.63). The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $961.03 million. Helmerich & Payne had a return on equity of 11.31% and a net margin of 11.02%. The firm's revenue for the quarter was up 47.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 EPS. On average, sell-side analysts forecast that Helmerich & Payne, Inc. will post 2.93 earnings per share for the current fiscal year.
Helmerich & Payne Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 30th. Shareholders of record on Thursday, May 15th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.47%. Helmerich & Payne's payout ratio is currently 32.89%.
Insider Buying and Selling
In related news, CEO John W. Lindsay purchased 20,000 shares of the business's stock in a transaction dated Monday, February 10th. The shares were purchased at an average cost of $27.55 per share, for a total transaction of $551,000.00. Following the completion of the acquisition, the chief executive officer now owns 691,214 shares in the company, valued at approximately $19,042,945.70. This trade represents a 2.98 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Belgacem Chariag purchased 37,356 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were bought at an average cost of $27.08 per share, with a total value of $1,011,600.48. Following the purchase, the director now directly owns 54,606 shares of the company's stock, valued at approximately $1,478,730.48. This represents a 216.56 % increase in their position. The disclosure for this purchase can be found here. 4.51% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Evercore ISI reissued an "in-line" rating and set a $39.00 price objective (down from $48.00) on shares of Helmerich & Payne in a research report on Wednesday, January 15th. Morgan Stanley reaffirmed an "underweight" rating and issued a $27.00 price objective on shares of Helmerich & Payne in a research report on Thursday, March 27th. Argus raised Helmerich & Payne to a "hold" rating in a report on Tuesday, February 11th. StockNews.com cut Helmerich & Payne from a "hold" rating to a "sell" rating in a research report on Friday. Finally, Susquehanna lowered their target price on shares of Helmerich & Payne from $43.00 to $28.00 and set a "positive" rating on the stock in a research note on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Helmerich & Payne currently has an average rating of "Hold" and an average target price of $31.20.
Get Our Latest Analysis on HP
About Helmerich & Payne
(
Free Report)
Founded in 1920, Helmerich & Payne, Inc (H&P) NYSE: HP is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders.
Further Reading

Before you consider Helmerich & Payne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helmerich & Payne wasn't on the list.
While Helmerich & Payne currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.